NASDAQ: IPHA
Innate Pharma Sa Stock Ownership - Who owns Innate Pharma Sa?

Insider buying vs selling

Have Innate Pharma Sa insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when IPHA insiders and whales buy or sell their stock.

IPHA Shareholders

What type of owners hold Innate Pharma Sa stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Liopoi0.00%81$129.60Institution
Lion Point Capital LP0.00%81$129.60Institution
Morsta0.00%44$70.40Institution
Morgan Stanley0.00%43$68.80Institution
Smapor0.00%24$38.40Institution
Smartharvest Portfolios LLC0.00%23$36.80Institution
Xtx Topco Ltd0.00%15$24.00Institution
Xtxtop0.00%15$24.00Institution
Citadel Advisors LLC0.00%12$19.20Institution
Citade0.00%12$19.20Institution

1 of 2

IPHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IPHA0.00%0.00%
CDXS0.06%67.55%Net Selling
ADCT0.06%43.59%Net Selling
MENS0.00%33.35%
MOLN0.01%0.00%

Innate Pharma Sa Stock Ownership FAQ

Who owns Innate Pharma Sa?

Innate Pharma Sa (NASDAQ: IPHA) is owned by 0.00% institutional shareholders, 0.00% Innate Pharma Sa insiders, and 100.00% retail investors. Liopoi is the largest individual Innate Pharma Sa shareholder, owning 81.00 shares representing 0.00% of the company. Liopoi's Innate Pharma Sa shares are currently valued at $132.03.

If you're new to stock investing, here's how to buy Innate Pharma Sa stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.